Innovation in merger analysis - How the EU Commission evaluated the case of Bayer-Monsanto

Posted by Carsten Guderian and Nabu Xavier on Sep 4, 2019 3:03:21 PM

In September 2016, the German drugs and chemicals group Bayer announced its intention to acquire the multinational Monsanto, known for its Roundup herbicide and GMOs. This merger would produce the world’s most powerful company in the seed and pesticide industry. On 21 March 2018 the EU commission released a Press Release announcing their approval of the acquisition of Monsanto by Bayer. The merger was approved on the conditional divestiture of an extensive remedy package, which addresses the parties' overlaps in seeds, pesticides and digital agriculture. It is for determining such inconspicuous aspects of a merger, like technology overlap, that the EU commission relied on the LexisNexis® PatentSight® database and our award-winning Business Intelligence software solution.

Read More

Tags: Technology, Science, Mergers and Acquisitions, Patent Analysis, Patent Valuation, Patent Asset Index, Patent Quality, M&A, Merger Evaluation, EU Commission, Competition Control